The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure
Not Applicable
- Conditions
- Scars
- Interventions
- Device: Lumenis fractional carbon dioxide laser
- Registration Number
- NCT00969475
- Lead Sponsor
- Moy-Fincher Medical Group
- Brief Summary
The purpose of this study is to determine if fractional carbon dioxide laser treatment of a fresh wound at the time of surgery, decreases scar formation. Scar revision is commonly done at 6-10 weeks following surgery. Therefore, it may be more beneficial, for both the patient and physician, to perform scar revision at the time of surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- Undergoing skin cancer surgery
- Will have a straight-line incision
- Fluent in English
- Must reside in the Los Angeles vicinity for the duration of the study
Exclusion Criteria
- Non-English speakers
- Pregnant or cognitively impaired subjects
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Laser resurfacing Lumenis fractional carbon dioxide laser Half of each subject's wound will be treated with a fractional CO2 laser.
- Primary Outcome Measures
Name Time Method Evidence of scar improvement as assessed by blinded-observer and patient ratings. At two and six weeks following the procedure
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Moy-Fincher Medical Group
🇺🇸Los Angeles, California, United States